首页> 外文期刊>Laboratory investigation >Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment
【24h】

Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment

机译:肿瘤微环境下头颈部鳞状细胞癌中肿瘤相关巨噬细胞亚群与CD47表达的关系

获取原文
获取外文期刊封面目录资料

摘要

Tumor-associated macrophages (TAM) have been classified into an immunostimulatory M1 subset against microbes and malignancies, and an immunoregulatory M2 subset that secretes immunosuppressive cytokines in order to repair tissues damaged by malignancies. The infiltration of M2 in the tumor microenvironment is known to facilitate immunosuppression and tumor-promoting properties. In the present study, we investigated the phagocytic potential of these macrophage subsets in oral squamous cell carcinoma (OSCC) in relation to the expression of CD47, the ‘don’t eat me’ signal against macrophages. The macrophage subsets M1 (induced by GM-CSF and IFN-γ) and M2 (induced by M-CSF and IL-10) were derived from the CD14+ cells of healthy donors. Phagocytosis of the CFSE-labeled CD47+ cell line HSC-3 by M1/M2 was assessed using flow cytometry and suppressed by an anti-CD47 neutralizing antibody or CD47 siRNA. Furthermore, CD68+ and CD163+ macrophage subset counts infiltrating tumor tissue and the expression of CD47 on cancer cells were examined immunohistochemically in 74 cases of OSCC, and their relationships with clinicopathological parameters or prognoses were determined. The phagocytic potential of M1 was similar to that of M2 in vitro. Phagocytosis by M1 increased in a CD47-dependent manner by the neutralizing antibody and siRNA, but did not in M2. An immunohistochemical (IHC) analysis revealed that the expression of CD47 did not correlate with macrophage subsets in peritumoral tissue or with any clinicopathological parameters; however, the stronger expression of CD47 by cancer cells and larger number of total macrophages/M2 were independently related to shorter survivals. Our results suggest that the expression of CD47 by cancer cells is related to evasion from phagocytosis, particularly that by M1 in vitro. IHC results indicate that various mechanisms are involved in the engulfing potential of TAM subsets in vivo.
机译:肿瘤相关巨噬细胞(TAM)已被分类为针对微生物和恶性肿瘤的免疫刺激性M1亚型,以及分泌免疫抑制性细胞因子以修复受恶性肿瘤破坏的组织的免疫调节性M2亚型。已知M2在肿瘤微环境中的渗透促进了免疫抑制和肿瘤促进特性。在本研究中,我们研究了口腔鳞状细胞癌(OSCC)中这些巨噬细胞亚群的吞噬潜能与CD47的表达有关,即CD44的“不要吃我”信号。巨噬细胞亚群M1(由GM-CSF和IFN-γ诱导)和M2(由M-CSF和IL-10诱导)来自健康供体的CD14 +细胞。使用流式细胞术评估CFSE标记的CD47 +细胞系HSC-3被M1 / M2吞噬,并被抗CD47中和抗体或CD47 siRNA抑制。此外,对74例OSCC患者中的CD68 +和CD163 +巨噬细胞亚群计数以及浸润性肿瘤组织中CD47的表达进行了免疫组织化学检查,并确定了它们与临床病理参数或预后的关系。在体外,M1的吞噬潜力与M2相似。 M1的吞噬作用通过中和抗体和siRNA以CD47依赖性方式增加,但在M2中却没有。免疫组织化学(IHC)分析显示,CD47的表达与肿瘤周围组织中的巨噬细胞亚群或任何临床病理参数无关。但是,癌细胞中CD47的更强表达和总巨噬细胞/ M2的数量更多与生存期短有关。我们的结果表明,癌细胞中CD47的表达与逃避吞噬有关,特别是在体外M1中。 IHC结果表明,体内TAM亚型的吞噬潜力涉及多种机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号